A 52-year-old woman with type 2 diabetes mellitus (HbA₁c 11.2%) and hypertension presents with a 3-day history of polyuria, polydipsia, and generalized weakness. She has been taking metformin 1000 mg twice daily and amlodipine 5 mg daily. On examination: BP 118/76 mmHg, HR 104/min, RR 24/min, temperature 37.2°C. Skin turgor is reduced. Capillary blood glucose: 486 mg/dL. Arterial blood gas: - pH: 7.32 - PaCO₂: 28 mmHg - HCO₃⁻: 15 mEq/L - PaO₂: 96 mmHg Serum electrolytes: - Na⁺: 132 mEq/L (corrected Na⁺: 137 mEq/L) - K⁺: 5.2 mEq/L - Cl⁻: 98 mEq/L - Anion gap: 19 mEq/L Serum creatinine: 1.1 mg/dL (baseline 0.9 mg/dL) Urine ketones: POSITIVE (3+) Venous blood glucose: 492 mg/dL What is the primary acid-base disturbance, and which metabolic pathway is predominantly responsible?

Explanation

## Acid-Base Diagnosis: High Anion Gap Metabolic Acidosis ### Step 1: Confirm Acidemia and Identify Primary Disorder - **pH 7.32** → Acidemia - **HCO₃⁻ 15 mEq/L** → LOW (metabolic origin) - **PaCO₂ 28 mmHg** → LOW (appropriate respiratory compensation) **Primary disorder: Metabolic acidosis** ### Step 2: Calculate and Interpret Anion Gap $$\text{Anion Gap} = [Na^+] - ([Cl^-] + [HCO_3^-])$$ $$\text{Anion Gap} = 132 - (98 + 15) = 19 \text{ mEq/L}$$ **Key Point:** Normal anion gap is 8–12 mEq/L. An anion gap of **19 mEq/L is HIGH**, indicating accumulation of **unmeasured anions** (lactate, ketones, or other organic acids). ### Step 3: Differential Diagnosis of High Anion Gap Metabolic Acidosis **Mnemonic:** **MUDPILES** = **M**ethanol, **U**remia, **D**iabetic ketoacidosis, **P**ropylene glycol, **I**soniazid, **L**actate, **E**thylene glycol, **S**alicylates In this case: - **Diabetes + hyperglycemia (486 mg/dL) + positive urine ketones (3+)** → **DKA** is the leading diagnosis - Metformin use in setting of acute illness raises concern for **metformin-associated lactic acidosis (MALA)**, but: - Serum creatinine is only mildly elevated (1.1 mg/dL) - No severe renal impairment (eGFR ~70 mL/min) - Urine ketones are strongly positive (3+), which is characteristic of DKA, not MALA ### Step 4: Confirm Respiratory Appropriateness Using Winter's formula: $$\text{Expected PaCO₂} = 1.5 \times [HCO_3^-] + 8 \pm 2 = 1.5 \times 15 + 8 \pm 2 = 22.5 + 8 \pm 2 = 28.5 \pm 2$$ $$\text{Expected range: 26.5–30.5 mmHg}$$ Actual PaCO₂ is **28 mmHg** (within expected range) → **Appropriate respiratory compensation** (hyperventilation). ### Step 5: Identify the Unmeasured Anion | Feature | DKA | MALA | |---------|-----|------| | **Urine ketones** | **3+ (strongly positive)** | Negative or trace | | **Serum glucose** | Markedly elevated (>250 mg/dL) | Variable | | **Renal function** | Often normal early | Impaired (Cr >2.0 mg/dL) | | **Clinical context** | Uncontrolled diabetes, infection, stress | Renal failure, contrast exposure, acute illness | | **Primary unmeasured anion** | **β-hydroxybutyrate, acetoacetate** | **Lactate** | **High-Yield:** The **3+ urine ketones** are pathognomonic for DKA. MALA does not produce significant ketonuria. ### Clinical Correlation **Clinical Pearl:** This patient has **Hyperglycemic Hyperosmolar State (HHS) with concurrent DKA** (overlap syndrome). The presence of: - Severe hyperglycemia (486 mg/dL) - Positive urine ketones (3+) - High anion gap (19 mEq/L) - Appropriate respiratory compensation - Mild hyponatremia (pseudohyponatremia from hyperglycemia) All point to **diabetic ketoacidosis** as the primary metabolic derangement, with ketone bodies (β-hydroxybutyrate and acetoacetate) as the unmeasured anions driving the anion gap. **Warning:** Do NOT confuse metformin use with MALA in this case. While metformin is a risk factor for MALA, the clinical and laboratory presentation (especially 3+ urine ketones) is classic for DKA, not MALA.